What is the approach to assessing hypocalcemia, including definition, differential diagnosis, history, physical examination, investigations, treatment, and referral indications?

Approach to Assessment of Hypocalcemia

Definition

Hypocalcemia is defined as ionized calcium <1.1 mmol/L (or <4.4 mg/dL), or total serum calcium <8.5 mg/dL (2.1 mmol/L), with severe hypocalcemia defined as total or albumin-corrected calcium <7.5 mg/dL (<1.87 mmol/l). 1, 2, 3

• Measure pH-corrected ionized calcium as the most accurate diagnostic method 4, 2
• Adjusted calcium (AdjCa) has only 78.2% sensitivity and 63.3% specificity for predicting low ionized calcium in critically ill patients and should not be relied upon exclusively 5

---

Differential Diagnosis

Organized by Phosphate Level:

Hypocalcemia with LOW serum phosphate:

• Vitamin D deficiency or malabsorption 6, 7
• Renal calcium wasting (loop diuretics) 3
• Hungry bone syndrome (post-parathyroidectomy) 6
• Acute pancreatitis 7

Hypocalcemia with NORMAL-to-HIGH serum phosphate:

• Hypoparathyroidism (75% post-surgical, 25% primary/genetic) 8
• Pseudohypoparathyroidism (PTH resistance) 6
• Chronic kidney disease 1
• Tumor lysis syndrome 7
• Rhabdomyolysis 7

Medication-induced causes:

• Bisphosphonates 3
• Cisplatin 3
• Loop diuretics 3
• Proton pump inhibitors 3
• Aminoglycosides 3
• Antiepileptics 3
• Calcimimetics (cinacalcet) - 7-9% develop severe hypocalcemia 1
• Massive blood transfusion (citrate-induced) 1, 9

---

History

Key Symptom Patterns:

Neuromuscular manifestations:

• Paresthesias (perioral, hands, feet) 2
• Muscle cramps and spasms 2
• Tetany 2, 7
• Seizures (may be first presentation) 2

Neuropsychiatric symptoms:

• Irritability, anxiety, depression 2
• Confusion or altered mental status 2
• Memory loss, hallucinations 7

Cardiovascular symptoms:

• Palpitations or syncope 2
• Symptoms of heart failure 2

Red Flags:

• Seizures in previously stable patient 2
• Cardiac arrhythmias or syncope 2, 9
• Laryngospasm or bronchospasm 7
• Tetany with carpopedal spasm 7

Risk Factors to Elicit:

Surgical history:

• Thyroid or parathyroid surgery (most common cause of hypoparathyroidism) 8
• Recent major surgery or trauma 4, 2

Biological stress periods:

• Acute illness, infection, sepsis 2
• Pregnancy or postpartum 2, 9
• Puberty 2

Genetic/congenital:

• 22q11.2 deletion syndrome (80% lifetime prevalence of hypocalcemia) 4, 2
• Family history of hypocalcemia or autoimmune disorders 6

Medication exposure:

• Recent chemotherapy (cisplatin) 3
• Bisphosphonate therapy 3
• Multiple blood transfusions 1, 9
• Chronic PPI or loop diuretic use 3

Dietary/lifestyle:

• Decreased oral calcium intake 2
• Alcohol consumption 4, 2
• Excessive carbonated beverage intake (especially colas) 4, 2

---

Physical Examination

Focused Examination Findings:

Neuromuscular assessment:

• Chvostek's sign (facial twitching with tapping facial nerve anterior to ear) 7
• Trousseau's sign (carpopedal spasm after 3 minutes of blood pressure cuff inflation 20 mmHg above systolic) 7
• Deep tendon reflexes (may be diminished or absent) 7

Cardiovascular examination:

• Heart rate and rhythm (bradycardia, arrhythmias) 1, 2
• Blood pressure (hypotension with severe hypocalcemia) 1

Neurological examination:

• Mental status assessment 2, 7
• Papilledema (if present) 7
• Signs of tetany or seizure activity 7

Skin examination:

• Dry skin, brittle nails 7
• Evidence of prior neck surgery (thyroidectomy scar) 8

---

Investigations

Initial Laboratory Tests:

Essential first-line tests:

• Ionized calcium (pH-corrected) - most accurate 4, 2
• Total serum calcium with albumin for correction 5
• Parathyroid hormone (PTH) - distinguishes hypoparathyroidism from other causes 4, 2, 6
• Serum phosphate - critical for differential diagnosis 6
• Magnesium - hypomagnesemia causes functional hypoparathyroidism 4, 2, 5
• Creatinine and eGFR - assess renal function 4, 2
• Albumin - for calcium correction 5

Secondary tests based on initial results:

• 25-hydroxyvitamin D level - if vitamin D deficiency suspected 2, 7
• 1,25-dihydroxyvitamin D - if renal disease or vitamin D metabolism disorder 7
• Alkaline phosphatase 6
• Thyroid function tests 4

Expected Findings by Etiology:

Hypoparathyroidism:

• Low/inappropriately normal PTH 6
• High-normal to high phosphate 6
• Low calcium 6

Vitamin D deficiency:

• High PTH (secondary hyperparathyroidism) 6
• Low phosphate 6
• Low 25-hydroxyvitamin D 7

CKD-related:

• High PTH 1
• High phosphate 1
• Low 1,25-dihydroxyvitamin D 1

Hypomagnesemia:

• Low magnesium (<1.5 mg/dL) 5
• Low/inappropriately normal PTH 7

Electrocardiogram:

• Prolonged QT interval (most common finding) 2
• Bradycardia 1
• Ventricular arrhythmias (if severe) 2
• Monitor continuously during calcium replacement 9

---

Empiric Treatment

Acute Symptomatic Hypocalcemia (Severe):

For life-threatening symptoms (seizures, tetany, arrhythmias, ionized Ca <0.8 mmol/L):

• Calcium chloride 10% solution: 10 mL IV (270 mg elemental calcium) over 10 minutes 1, 9
• Calcium chloride is preferred over calcium gluconate in liver dysfunction or massive transfusion 1
• Continuous ECG monitoring during rapid administration due to arrhythmia risk 9
• May repeat bolus or start continuous infusion if symptoms persist 9

Alternative for less severe acute symptoms:

• Calcium gluconate 10% solution: 10-20 mL IV (93-186 mg elemental calcium) over 10 minutes 9
• Dilute in 50-100 mL of 5% dextrose or normal saline 9

Critical monitoring during IV calcium:

• Serum calcium every 1-4 hours during continuous infusion 9
• Serum calcium every 4-6 hours during intermittent boluses 9
• Continuous ECG monitoring 9

Mild-to-Moderate Hypocalcemia:

Oral calcium supplementation:

• Calcium carbonate 1000-2000 mg elemental calcium daily in divided doses (provides highest elemental calcium content) 2
• Total elemental calcium intake should not exceed 2000 mg/day 2

Vitamin D supplementation:

• Cholecalciferol or ergocalciferol for vitamin D deficiency 2
• Calcitriol 0.5 μg daily for hypoparathyroidism (in patients >12 months old) 2
• Combination of calcium and vitamin D is more effective than either alone 2

Magnesium replacement (if hypomagnesemia present):

• Must correct magnesium before calcium will normalize 4, 2
• Magnesium sulfate or magnesium oxide supplementation 2

Special Populations:

CKD patients (G3a-G5D):

• Use individualized approach rather than routine correction of mild hypocalcemia 1
• Avoid hypercalcemia (maintain <10.2 mg/dL) 2
• Maintain calcium-phosphorus product <55 mg²/dL 2
• Dialysate calcium concentration 1.25-1.50 mmol/L (2.5-3.0 mEq/L) 1

Renal impairment:

• Start at lowest recommended dose 9
• Monitor serum calcium every 4 hours 9

Elderly patients:

• Start at low end of dosage range 9

Pregnant/lactating women:

• Maternal hypocalcemia increases risk of spontaneous abortion, preterm labor, preeclampsia 9
• Monitor neonates for hypocalcemia or hypercalcemia 9

---

Indications to Refer

Endocrinology Referral:

• Confirmed hypoparathyroidism (surgical or primary) requiring long-term management 2
• Genetic causes (22q11.2 deletion syndrome, familial hypocalcemia) 4, 2
• Recurrent or refractory hypocalcemia despite standard treatment 2
• Need for calcitriol or other active vitamin D metabolites 2
• CKD-MBD requiring specialized management 1

Nephrology Referral:

• CKD stage G3b or higher with hypocalcemia 1
• Hypocalcemia with hyperphosphatemia and elevated creatinine 1
• Dialysis patients with calcium management issues 1

Genetics Referral:

• Suspected 22q11.2 deletion syndrome 4, 2
• Family history suggesting hereditary hypoparathyroidism 6
• Dysmorphic features or developmental delay with hypocalcemia 4

Emergency/ICU Consultation:

• Severe symptomatic hypocalcemia (seizures, tetany, cardiac arrhythmias) 1, 2
• Ionized calcium <0.8 mmol/L 1
• QT prolongation with cardiac symptoms 2

---

Critical Pitfalls

Diagnostic Pitfalls:

• Relying on adjusted calcium alone in critically ill patients - ionized calcium is essential as AdjCa has poor sensitivity/specificity 5
• Missing hypomagnesemia - calcium will not correct until magnesium is repleted 4, 2, 5
• Overlooking medication causes - particularly calcimimetics (7-9% severe hypocalcemia), bisphosphonates, and massive transfusion 1, 3
• Failing to check PTH level - critical for distinguishing hypoparathyroidism from other causes 6
• Confusing hypocalcemia symptoms with psychiatric conditions (anxiety, depression) 2

Treatment Pitfalls:

• Rapid IV calcium administration without ECG monitoring - risk of fatal arrhythmias, especially with concurrent digoxin use 9
• Mixing calcium with phosphate or bicarbonate-containing solutions - causes precipitation 9
• Ceftriaxone co-administration in neonates ≤28 days - absolutely contraindicated due to fatal lung/kidney precipitates 9
• Overcorrection causing hypercalcemia - leads to renal calculi and renal failure 4, 2
• Aluminum toxicity in neonates - calcium gluconate contains up to 400 mcg/L aluminum; limit to <4-5 mcg/kg/day 9
• Extravasation of IV calcium - causes tissue necrosis, calcinosis cutis; discontinue immediately if occurs 9

Monitoring Pitfalls:

• Inadequate calcium monitoring during treatment - check every 1-4 hours during continuous infusion, every 4-6 hours with intermittent dosing 9
• Not monitoring calciuria - risk of nephrocalcinosis with vitamin D metabolites 2
• Ignoring calcium-phosphorus product - maintain <55 mg²/dL to prevent metastatic calcification 2
• Failure to normalize calcium by day 4 in severe hypocalcemia - associated with doubled mortality (38% vs 19%) 5

Special Population Pitfalls:

• Treating mild hypocalcemia aggressively in CKD patients on calcimimetics - EVOLVE trial showed no adverse outcomes with persistently low calcium 1
• Not monitoring neonates born to hypocalcemic mothers - risk of neonatal hyperparathyroidism and seizures 9
• Inadequate monitoring during biological stress (surgery, infection, pregnancy) - periods of highest risk for decompensation 4, 2